Ingrid Stenstadvold Ross has been Chief Executive Officer of the Norwegian Cancer Society since March 2020, leading Norway’s largest cancer NGO. She has overseen the organisation’s largest research funding rounds, distributing up to 220 million NOK to leading cancer projects and supporting individual investigator grants of up to 8 million NOK. Ross has strengthened the Society’s strategic role in research, prevention, and patient support, building partnerships with national and international institutions to advance innovation and equitable access to care.
Under her leadership, the Society has expanded collaborations with organisations such as Cancer Research UK to accelerate drug development and clinical trials in Norway. She champions public health initiatives and policy reforms, including Norway’s participation in EU cancer research frameworks, early detection programs, and patient access initiatives. Ross also represents the Society in European and Nordic cancer networks, including the Oslo Cancer Cluster and the Nordic Cancer Union, further enhancing its influence on national cancer policy and positioning it as a key driver of research and cancer care improvements in Norway and beyond.
The 100 CEOs featured here reflect the diversity and complexity of modern oncology leadership. In 2025, some lead the world’s largest cancer institutions; others guide specialized societies or emerging innovators. What unites them is responsibility: for millions of patients, for the integrity of science, and for the future direction of cancer care globally.
This list is not a celebration of power, but a recognition of stewardship, accountability, and impact – and of the leaders whose choices continue to shape the fight against cancer. For the many deserving individuals not mentioned in this list, we will continue to acknowledge, honor and elevate your voices in our daily publications from across the world.
See the full list of The 100 Influential CEOs in Oncology in 2025 and stay tuned for other special category nominations
